Canada markets closed

Scinai Immunotherapeutics Ltd. (SCNI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4499+0.0181 (+4.19%)
At close: 04:00PM EDT
0.4700 +0.02 (+4.47%)
After hours: 07:42PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
6,017
5,765
3,249
16,004
Selling General and Administrative
4,888
5,296
7,625
5,018
Total Operating Expenses
10,905
11,061
10,862
-2,281
Operating Income or Loss
-10,905
-11,061
-10,862
2,281
Interest Expense
-
-
3,486
348.9294
Total Other Income/Expenses Net
-
-
1,839
-3,305
Income Before Tax
-9,286
-5,796
-8,206
-1,385
Income from Continuing Operations
-9,286
-5,796
-8,206
-1,385
Net Income
-9,286
-5,796
-8,206
-1,385
Net Income available to common shareholders
-9,286
-5,796
-8,206
-1,385
Basic EPS
-4.40
-4.00
-8.00
-1.24
Diluted EPS
-4.40
-4.00
-8.00
-1.24
Basic Average Shares
3,641
1,885
1,411
1,108
Diluted Average Shares
3,641
1,885
1,411
1,108